메뉴 건너뛰기




Volumn 3, Issue 4, 2001, Pages 574-583

Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation

Author keywords

Dogs; Electroporation; Factor IX; Hemophilia; Muscle; PINC; Plasmid

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 9; CREATINE KINASE; PLASMID DNA; POLYMER;

EID: 0034985202     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0295     Document Type: Article
Times cited : (89)

References (36)
  • 1
    • 0032725075 scopus 로고    scopus 로고
    • Gene therapy for hemophilia A and B: Patient selection and follow-up, requirements for a cure
    • (1999) Thromb. Haemostasis , vol.82 , pp. 572-575
    • Lusher, J.M.1
  • 25
    • 0028842611 scopus 로고
    • Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter
    • (1995) Hum. Gene Ther. , vol.6 , pp. 1291-1297
    • Harms, J.S.1    Splitter, G.A.2
  • 32
  • 36


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.